Article Sidebar

Submitted
November 13, 2024
Accepted
November 13, 2024
Published
November 13, 2024
Download
PDF
Statistic
Read Counter : 529 Download : 512

Main Article Content

Abstract

Background: Any area of the urinary system—the kidneys, ureters, bladder, or urethra—is
susceptible to infection when a UTI occurs. The urethra and bladder are the most common sites
of infection in the lower urinary tract. When microorganisms including bacteria, viruses, fungi,
and parasites evolve to resist antibiotics, a phenomenon known as antimicrobial resistance
(AMR) happens. This makes infections more difficult to cure and raises the likelihood of disease
transmission, serious illness, and death. The researchers in this study set out to quantify the
prevalence of urinary tract infections (UTIs) in Iraqi residents and to determine which bacterial
strains were resistant to antibiotics.
Methods: The study included 100 patients who were classified into 75 that were diagnosed
with UTI patients, their ages ranged between (16) to (67) years, (45) females and (30) males. In
addition to 25 uninfected individuals as controls, their ages ranged between (15) to (59) years,
(15) females and (10) males. All participants in the study underwent identical laboratory tests to
diagnose UTIs, identify the types of bacterial isolates, and determine their antibiotic resistance
patterns
Results: The result of the present study shows that E.coli, Klebsiella pneumonia and
pseudomonas aeruginosa were the most common types of UTI-associated bacteria with the
percentage of 44.71%, 38.57% and 15.71% respectively.
Conclusion: pseudomonas aeruginosa had been developed its resistance to several antibiotics
and had great predisposition to be MDR.

Keywords

Urinary tract infections Escherichea coli Klebsiella pneumonia Pseudomonas aeruginosa drug resistance

Article Details

License

Copyright (c) 2024 University of Thi-Qar Journal Of Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Hooton, T. M. (2012). Uncomplicated urinary tract infection. New England Journal of
  2. Medicine, 366(11), 1028-1037. doi: 10.1056/NEJMcp1104429.
  3. Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015). Urinary tract
  4. infections: epidemiology, mechanisms of infection and treatment options. Nature reviews
  5. microbiology, 13(5), 269-284. doi: 10.1038/nrmicro3432.
  6. Khawcharoenporn, T., Vasoo, S., & Singh, K. (2013). Urinary tract infections due to
  7. multidrug‐resistant Enterobacteriaceae: prevalence and risk factors in a Chicago emergency
  8. department. Emergency medicine international, 2013(1), 258517. doi: 10.1155/2013/258517.
  9. Finucane, T. E. (2017). “Urinary tract infection”—requiem for a heavyweight. Journal of
  10. the American Geriatrics Society, 65(8), 1650-1655. doi: 10.1111/jgs.14907.
  11. Morello, W., La Scola, C., Alberici, I., & Montini, G. (2016). Acute pyelonephritis in
  12. children. Pediatric Nephrology, 31, 1253-1265. doi: 10.1007/s00467-015-3168-5.
  13. Fouts, D. E., Pieper, R., Szpakowski, S., Pohl, H., Knoblach, S., Suh, M. J., ... & Groah,
  14. S. L. (2012). Integrated next-generation sequencing of 16S rDNA and metaproteomics
  15. differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder
  16. associated with spinal cord injury. Journal of translational medicine, 10, 1-17. doi:
  17. 1186/1479-5876-10-174.
  18. Schlager, T. A. (2016). Urinary tract infections in infants and children. Microbiology
  19. spectrum, 4(5), 10-1128. doi: 10.1128/microbiolspec.UTI-0022-2016.
  20. Desai, D. J., Gilbert, B., & McBride, C. A. (2016). Paediatric urinary tract infections:
  21. Diagnosis and treatment. Australian family physician, 45(8), 558-564.
  22. Östholm-Balkhed, Å., Tärnberg, M., Nilsson, M., Nilsson, L. E., Hanberger, H.,
  23. Hällgren, A., & Travel Study Group of Southeast Sweden. (2013). Travel-associated faecal
  24. colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. Journal of
  25. Antimicrobial Chemotherapy, 68(9), 2144-2153. doi: 10.1093/jac/dkt167.
  26. Sekar, R., Srivani, S., Amudhan, M., & Mythreyee, M. (2016). Carbapenem resistance in
  27. a rural part of southern India: Escherichia coli: versus: Klebsiella: spp. Indian Journal of Medical
  28. Research, 144(5), 781-783. doi: 10.4103/ijmr.IJMR_1035_15.
  29. Lee, C. R., Cho, I. H., Jeong, B. C., & Lee, S. H. (2013). Strategies to minimize antibiotic
  30. resistance. International journal of environmental research and public health, 10(9), 4274-4305.
  31. doi: 10.3390/ijerph10094274.
  32. Graif, N., Abozaid, S., & Peretz, A. (2020). Trends in distribution and antibiotic
  33. resistance of bacteria isolated from urine cultures of children in Northern Israel between 2010
  34. and 2017. Microbial Drug Resistance, 26(11), 1342-1349. doi: 10.1089/mdr.2020.0111.
  35. Mirsoleymani, S. R., Salimi, M., Shareghi Brojeni, M., Ranjbar, M., & Mehtarpoor, M.
  36. (2014). Bacterial Pathogens and Antimicrobial Resistance Patterns in Pediatric Urinary Tract
  37. Infections: A Four‐Year Surveillance Study (2009–2012). International journal of pediatrics,
  38. (1), 126142. doi: 10.1155/2014/126142.
  39. Lee, H. Y., & Khosla, C. (2007). Bioassay-guided evolution of glycosylated macrolide
  40. antibiotics in Escherichia coli. PLoS biology, 5(2), e45. doi: 10.1371/journal.pbio.0050045.
  41. Mandell, L. A., Marrie, T. J., Grossman, R. F., Chow, A. W., Hyland, R. H., & Canadian
  42. Community-Acquired Pneumonia Working Group. (2000). Canadian guidelines for the initial
  43. management of community-acquired pneumonia: an evidence-based update by the Canadian
  44. Infectious Diseases Society and the Canadian Thoracic Society. Clinical Infectious Diseases,
  45. (2), 383-421. doi: 10.1155/2000/457147.
  46. Merkier, A. K., Rodríguez, M. C., Togneri, A., Brengi, S., Osuna, C., Pichel, M., ... &
  47. Centrón, D. (2013). Outbreak of a cluster with epidemic behavior due to Serratia marcescens
  48. after colistin administration in a hospital setting. Journal of clinical microbiology, 51(7), 2295
  49. doi: 10.1128/JCM.03280-12
  50. Mielko, K. A., Jabłoński, S. J., Milczewska, J., Sands, D., Łukaszewicz, M., & Młynarz,
  51. P. (2019). Metabolomic studies of Pseudomonas aeruginosa. World Journal of Microbiology and
  52. Biotechnology, 35, 1-11. doi: 10.1007/s11274-019-2739-1.
  53. Tingpej, P., Smith, L., Rose, B., Zhu, H., Conibear, T., Al Nassafi, K., ... & Harbour, C.
  54. (2007). Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains
  55. isolated from lungs of adults with cystic fibrosis. Journal of clinical microbiology, 45(6), 1697
  56. doi: 10.1128/JCM.02364-06.
  57. Foxman, B. (2014). Urinary tract infection syndromes: occurrence, recurrence,
  58. bacteriology, risk factors, and disease burden. Infectious Disease Clinics, 28(1), 1-13. doi:
  59. 1016/j.idc.2013.09.003.
  60. Hsueh, P. R., Hoban, D. J., Carmeli, Y., Chen, S. Y., Desikan, S., Alejandria, M., ... &
  61. Binh, T. Q. (2011). Consensus review of the epidemiology and appropriate antimicrobial therapy
  62. of complicated urinary tract infections in Asia-Pacific region. Journal of infection, 63(2), 114
  63. doi: 10.1016/j.jinf.2011.05.015.
  64. A‘t Hoen, L., Bogaert, G., Radmayr, C., Dogan, H. S., Nijman, R. J., Quaedackers, J., ...
  65. & Stein, R. (2021). Update of the EAU/ESPU guidelines on urinary tract infections in children.
  66. Journal of pediatric urology, 17(2), 200-207. doi: 10.1016/j.jpurol.2021.01.037.
  67. Esposito, S., Biasucci, G., Pasini, A., Predieri, B., Vergine, G., Crisafi, A., ... & Iughetti,
  68. L. (2022). Antibiotic resistance in paediatric febrile urinary tract infections. Journal of global
  69. antimicrobial resistance, 29, 499-506. doi: 10.1016/j.jgar.2021.11.003.
  70. Boucher, H. W., & Corey, G. R. (2008). Epidemiology of methicillin-resistant
  71. Staphylococcus aureus. Clinical infectious diseases, 46(Supplement_5), S344-S349. doi:
  72. 1086/533590.
  73. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C.
  74. G., ... & Monnet, D. L. (2012). Multidrug-resistant, extensively drug-resistant and pandrug
  75. resistant bacteria: an international expert proposal for interim standard definitions for acquired
  76. resistance. Clinical microbiology and infection, 18(3), 268-281. doi: 10.1111/j.1469
  77. 2011.03570.x.
  78. Zavodnick, J., Harley, C., Zabriskie, K., & Brahmbhatt, Y. (2020). Effect of a female
  79. external urinary catheter on incidence of catheter-associated urinary tract infection. Cureus,
  80. (10). doi: 10.7759/cureus.11113.
  81. Alliance for the Prudent Use of Antibiotics. (2016). General background: about antibiotic
  82. resistance. Tufts University School of Medicine, 136.
  83. Murray, C. J., Ikuta, K. S., Sharara, F., Swetschinski, L., Aguilar, G. R., Gray, A., ... &
  84. Tasak, N. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic
  85. analysis. The lancet, 399(10325), 629-655. doi: 10.1016/S0140-6736(21)02724-0.
  86. Aghamohammad, S., Badmasti, F., Solgi, H., Aminzadeh, Z., Khodabandelo, Z., &
  87. Shahcheraghi, F. (2020). First report of extended-spectrum betalactamase-producing Klebsiella
  88. pneumoniae among fecal carriage in Iran: high diversity of clonal relatedness and virulence
  89. factor profiles. Microbial Drug Resistance, 26(3), 261-269. doi: 10.1089/mdr.2018.0181.
  90. Degtiar, N. V., Litovchenko, P. P., Znamenskiĭ, V. A., Abu-el-Khava, M. I., &
  91. Nazarchuk, L. V. (1985). Identification of Pseudomonas and other similar gram-negative non
  92. glucose-fermenting bacteria using a minimal number of tests. Laboratornoe Delo, (5), 311-314.
  93. doi: 10.1128/am.15.3.661-664.1967.
  94. Diggle, S. P., & Whiteley, M. (2020). Microbe Profile: Pseudomonas aeruginosa:
  95. opportunistic pathogen and lab rat. Microbiology, 166(1), 30-33. doi: 10.1099/mic.0.000860.
  96. Hu, F., Zhu, D., Wang, F., & Wang, M. (2018). Current status and trends of antibacterial
  97. resistance in China. Clinical Infectious Diseases, 67(suppl_2), S128-S134. doi:
  98. 1093/cid/ciy657.
  99. Ahmed, I., Rabbi, M. B., & Sultana, S. (2019). Antibiotic resistance in Bangladesh: A
  100. systematic review. International Journal of Infectious Diseases, 80, 54-61. doi:
  101. 1016/j.ijid.2018.12.017.
  102. Effah, C. Y., Sun, T., Liu, S., & Wu, Y. (2020). Klebsiella pneumoniae: an increasing
  103. threat to public health. Annals of clinical microbiology and antimicrobials, 19, 1-9. doi:
  104. 1186/s12941-019-0343-8.
  105. Subedi, D., Vijay, A. K., & Willcox, M. (2018). Overview of mechanisms of antibiotic
  106. resistance in Pseudomonas aeruginosa: an ocular perspective. Clinical and Experimental
  107. Optometry, 101(2), 162-171. doi: 10.1111/cxo.12621.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)